THE ROLE OF CYTOLOGICAL AND MOLECULAR-GENETIC LABORATORY DIAGNOSTICS IN THE EARLY DETECTION OF CERVICAL PRECANCEROUS LESIONS

Background: Cervical cancer remains one of the major public health challenges worldwide. Persistent infection with high-risk human papillomavirus (HPV) is recognized as the principal etiological factor in the development of cervical precancerous lesions and cervical cancer. Early detection of these lesions is essential for preventing disease progression and reducing cervical cancer-related mortality. Objective: This article aims to evaluate the importance of cytological and molecular-genetic laboratory diagnostic methods in the early detection of cervical precancerous lesions and to highlight their complementary role in modern cervical cancer screening programs. Methods: A narrative review of scientific literature and international clinical guidelines was conducted, focusing on conventional cervical cytology, liquid-based cytology, HPV DNA testing, polymerase chain reaction (PCR), HPV genotyping, and immunocytochemical biomarkers. Results: Cytological examination, particularly the Papanicolaou (Pap) test, remains an important method for identifying morphological abnormalities in cervical epithelial cells. Molecular-genetic techniques provide additional information by detecting high-risk HPV infections, including HPV genotypes 16 and 18, which are strongly associated with cervical carcinogenesis. The combination of cytological and molecular-genetic approaches improves risk assessment and supports the identification of women who require further diagnostic evaluation. Emerging methods, including p16/Ki-67 dual-stain cytology, provide additional opportunities for identifying transforming HPV infections. Conclusion: The integration of cytological and molecular-genetic laboratory diagnostics plays a significant role in the early detection of cervical precancerous lesions. A combined diagnostic approach can improve screening effectiveness, facilitate timely clinical intervention, and contribute to the prevention of invasive cervical cancer.

Authors

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-11-19
DOI
https://doi.org/10.5281/zenodo.24366397
Primary Topic
Cervical Cancer and HPV Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

THE ROLE OF CYTOLOGICAL AND MOLECULAR-GENETIC LABORATORY DIAGNOSTICS IN THE EARLY DETECTION OF CERVICAL PRECANCEROUS LESIONS

Azizbek Akramjon o'g'li A'zamjonov
Zenodo (CERN European Organization for Nuclear Research)
Cervical Cancer and HPV Research
article

THE ROLE OF CYTOLOGICAL AND MOLECULAR-GENETIC LABORATORY DIAGNOSTICS IN THE EARLY DETECTION OF CERVICAL PRECANCEROUS LESIONS

Azizbek Akramjon o'g'li A'zamjonov
article en

Abstract

Background: Cervical cancer remains one of the major public health challenges worldwide. Persistent infection with high-risk human papillomavirus (HPV) is recognized as the principal etiological factor in the development of cervical precancerous lesions and cervical cancer. Early detection of these lesions is essential for preventing disease progression and reducing cervical cancer-related mortality. Objective: This article aims to evaluate the importance of cytological and molecular-genetic laboratory diagnostic methods in the early detection of cervical precancerous lesions and to highlight their complementary role in modern cervical cancer screening programs. Methods: A narrative review of scientific literature and international clinical guidelines was conducted, focusing on conventional cervical cytology, liquid-based cytology, HPV DNA testing, polymerase chain reaction (PCR), HPV genotyping, and immunocytochemical biomarkers. Results: Cytological examination, particularly the Papanicolaou (Pap) test, remains an important method for identifying morphological abnormalities in cervical epithelial cells. Molecular-genetic techniques provide additional information by detecting high-risk HPV infections, including HPV genotypes 16 and 18, which are strongly associated with cervical carcinogenesis. The combination of cytological and molecular-genetic approaches improves risk assessment and supports the identification of women who require further diagnostic evaluation. Emerging methods, including p16/Ki-67 dual-stain cytology, provide additional opportunities for identifying transforming HPV infections. Conclusion: The integration of cytological and molecular-genetic laboratory diagnostics plays a significant role in the early detection of cervical precancerous lesions. A combined diagnostic approach can improve screening effectiveness, facilitate timely clinical intervention, and contribute to the prevention of invasive cervical cancer.

Zenodo (CERN European Organization for Nuclear Research)
Cervical Cancer and HPV Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon